Neonatal IRT FEIA
Sensitive and Reliable Screening for Cystic Fibrosis in Newborns A fluorometric enzyme immunoassay designed for the accurate determination of human ...
Overview
Labsystems Diagnostics Neonatal IRT FEIA is a fluorometric enzyme immunoassay for the quantitative measurement of human immunoreactive trypsinogen (IRT) from dried blood spot samples. IRT is eluted from blood disks and forms a sandwich complex between a solid-phase antibody that recognizes Trypsinogen 1 (IRT1) and an enzyme-labeled antibody tagged with horseradish peroxidase (HRP). This method delivers precise and reproducible results essential for newborn screening programs to identify potential cystic fibrosis cases early.
Features
- Quantitative determination of IRT from dried blood spot samples
- Based on fluorometric enzyme immunoassay (FEIA) technology
- High analytical sensitivity with fluorescence detection
- Compatible with Labsystems Diagnostics NS2400 automation system
- Stable reagents ensure consistent performance across runs
- Simple and reliable workflow similar to TSH and 17-OHP assays
Technical Specifications
- Principle : Fluorometric Enzyme Immunoassay (FEIA)
- Format : 10 Solid Plates (96 wells each)
- Total Wells : 960
- Catalogue Number : 6199831
- Detection : Fluorescence
- Compatibility : NS2400 Automation System
IS Modules & Benefits
IS Modules
- Compatible with Labsystems Diagnostics NS2400
- Integrates seamlessly into automated newborn screening workflows
- Optimized for high-throughput and standardized analysis
Benefits
- High Sensitivity: Fluorescence detection ensures precise measurement of low IRT concentrations.
- Ease of Use: Follows a simple and standardized procedure used in other neonatal screening assays.
- Reliable Performance: Stable reagents maintain assay integrity over time.
- Automation Ready: Fully compatible with NS2400 for efficient, large-scale screening.